These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 13434362)

  • 1. [Depot vaccines. II. Method for estimation of virus content in exstirpated deposits of PR-8-influenza virus-gamma-aluminum oxide vaccines].
    DRESCHER J
    Zentralbl Bakteriol Orig; 1957 Apr; 168(3-4):181-93. PubMed ID: 13434362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on adsorption vaccines. I. Examination of the course of gamma-aluminum-oxide resorption from deposits of PR 8 influenza virus gamma-aluminum-oxide vaccines].
    HENNEBERG G; DRESCHER J
    Zentralbl Bakteriol Orig; 1956 Dec; 167(4):310-26. PubMed ID: 13410040
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of the value of influenza virus vaccine in guinea pig].
    HENNEBERG G; WAGNER L
    Zentralbl Bakteriol Orig; 1953 Sep; 159(8):482-5. PubMed ID: 13123282
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on anti-influenzal vaccination. II. Comparison of immunization response to intradermal vaccination with a single and double dose].
    GIORDANO G; PINO G
    Riv Ist Sieroter Ital; 1953; 28(6):501-9. PubMed ID: 13168107
    [No Abstract]   [Full Text] [Related]  

  • 5. Influenza vaccines and vaccination strategies in birds.
    van den Berg T; Lambrecht B; Marché S; Steensels M; Van Borm S; Bublot M
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):121-65. PubMed ID: 17889937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of trial vaccination against influenza in the winter of 1952-53].
    VERLINDE JD; MAKSTENIEKS O
    Ned Tijdschr Geneeskd; 1954 Feb; 98(9):559-65. PubMed ID: 13154479
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New possibilities of active immunization against influenza].
    PATOCKA F; SLONIM D
    Prakt Lek; 1954 Oct; 34(20):463-5. PubMed ID: 13236838
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eccentric exercise as an adjuvant to influenza vaccination in humans.
    Edwards KM; Burns VE; Allen LM; McPhee JS; Bosch JA; Carroll D; Drayson M; Ring C
    Brain Behav Immun; 2007 Feb; 21(2):209-17. PubMed ID: 16824730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influenza vaccination: NOW!].
    Heinzl S
    Med Monatsschr Pharm; 2006 Nov; 29(11):389. PubMed ID: 17131684
    [No Abstract]   [Full Text] [Related]  

  • 13. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines.
    Kapteyn JC; Porre AM; de Rond EJ; Hessels WB; Tijms MA; Kessen H; Slotboom AM; Oerlemans MA; Smit D; van der Linden J; Schoen P; Thus JL
    Vaccine; 2009 Feb; 27(9):1468-77. PubMed ID: 19110022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients.
    Avetisyan G; Ragnavölgyi E; Toth GT; Hassan M; Ljungman P
    Bone Marrow Transplant; 2005 Sep; 36(5):411-5. PubMed ID: 15980884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
    Ohba K; Yoshida S; Zahidunnabi Dewan M; Shimura H; Sakamaki N; Takeshita F; Yamamoto N; Okuda K
    Vaccine; 2007 May; 25(21):4291-300. PubMed ID: 17403560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza control in the 21st century: Optimizing protection of older adults.
    Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I
    Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
    Beyer WE; Palache AM; Lüchters G; Nauta J; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):125-32. PubMed ID: 15163500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
    Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.